Dr.ย Eliย Rosenbaum
MD (Doctor of Medicine)
Senior Oncologist, Genitourinary Oncology
corporate_fareRabin Medical Center / Davidoff Cancer Center, Petah Tikva
Eli Rosenbaum
MD (Doctor of Medicine)
Prof. Eli Rosenbaum, MD, is a senior oncologist specialising in genitourinary oncology at Rabin Medical Center's Davidoff Cancer Center in Petah Tikva, Israel. With over 20 years of experience, his practice centres on the diagnosis, treatment planning and multidisciplinary management of prostate cancer, kidney cancer, bladder cancer and testicular cancer.
Prof. Rosenbaum has trained at Tel Aviv University and undertaken advanced oncology training in the United States, bringing an international perspective to his clinical work. At the Uro-Oncology Clinic of the Davidoff Cancer Center, he manages complex cases involving high-risk prostate cancer, metastatic renal cell carcinoma, muscle-invasive bladder cancer and recurrent disease after prior surgery or systemic therapy. His treatment toolkit includes novel hormonal agents such as enzalutamide and abiraterone, cabozantinib for advanced renal cell carcinoma, immunotherapy for eligible patients, and coordinated multidisciplinary tumour-board planning. He is widely regarded as a leading GU oncology specialist in Israel, with a strong focus on translating current evidence into personalised treatment decisions for each patient.
Why Consider Prof. Eli Rosenbaum?
Prof. Rosenbaum brings over two decades of focused GU oncology expertise to complex prostate, kidney and bladder cancer cases, working within one of Israel's most advanced cancer centres.
Areas of Specialisation
Focused expertise in prostate, kidney, bladder and other genitourinary cancers
Prof. Rosenbaum specialises in the full spectrum of genitourinary cancers, with particular depth in advanced prostate cancer, renal cell carcinoma and muscle-invasive bladder cancer. His multidisciplinary approach integrates systemic therapy, radiation planning and surgical coordination.
Prostate Cancer
Comprehensive management of localized, high-risk, metastatic and castration-resistant prostate cancer.
- arrow_rightMetastatic hormone-sensitive prostate cancer (mHSPC) treatment planning
- arrow_rightCastration-resistant prostate cancer (CRPC) management
- arrow_rightNovel hormonal agents: enzalutamide and abiraterone
- arrow_rightEvaluation for radioligand therapy where applicable
- arrow_rightHigh-risk localized prostate cancer treatment coordination
- arrow_rightRising PSA after surgery or radiotherapy โ salvage planning
- arrow_rightMultidisciplinary review with radiation oncology and urology
Kidney Cancer (Renal Cell Carcinoma)
Systemic therapy and multidisciplinary planning for advanced and metastatic kidney cancer.
- arrow_rightTargeted therapy including cabozantinib and other TKIs
- arrow_rightImmunotherapy combinations for eligible patients
- arrow_rightTreatment sequencing for metastatic or recurrent disease
- arrow_rightClinical trial evaluation for advanced kidney cancer
Bladder & Urothelial Cancer
Evidence-based management of muscle-invasive and advanced urothelial carcinoma.
- arrow_rightMuscle-invasive bladder cancer (MIBC) multidisciplinary planning
- arrow_rightChemotherapy and immunotherapy for advanced urothelial carcinoma
- arrow_rightBladder-preservation strategy evaluation
- arrow_rightRecurrent urothelial cancer second-line therapy
Procedures & Clinical Services
Treatment planning and clinical approaches offered by Prof. Rosenbaum
Prof. Rosenbaum offers comprehensive GU oncology consultations that may include systemic therapy planning, second opinions, treatment sequencing for recurrent disease, and multidisciplinary coordination across surgery, radiation and medical oncology.
Medical Oncology for GU Cancers
Medical OncologySystemic cancer treatment planning tailored to each patient's cancer type, stage and prior therapy.
Targeted Therapy
Targeted TherapyBiomarker-guided targeted treatment selection for eligible genitourinary cancer patients.
Multidisciplinary Treatment Planning
MultidisciplinaryCoordinated tumour-board-level planning across GU surgery, radiation oncology and medical oncology.
Second Opinion & Complex Disease Review
Second OpinionExpert review for patients with recurrent, refractory or complex GU cancers seeking a second perspective.
Research & Publications
Clinical research and academic contributions in genitourinary oncology
Prof. Rosenbaum has contributed to clinical research in urological cancers, including prostate, kidney and bladder cancer. His research activity spans treatment strategies, neoadjuvant approaches, and systemic therapy for advanced GU malignancies.
Prof. Rosenbaum is associated with clinical research in GU oncology at Rabin Medical Center. A detailed publication list may be available on request through the Davidoff Cancer Center.
Education & Training
Prof. Rosenbaum completed his medical training at Tel Aviv University and pursued advanced oncology training in the United States, building a strong academic and clinical foundation in genitourinary oncology.
Clinical Experience
Prof. Eli Rosenbaum has over 20 years of experience as a senior GU oncology specialist at Rabin Medical Center in Israel. He leads complex case management across prostate, kidney, bladder and testicular cancers, combining evidence-based systemic therapy with multidisciplinary clinical collaboration.
Languages & International
Prof. Rosenbaum consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients who require assistance in languages beyond English and Hebrew.
CancerFax can coordinate professional medical interpreter support for international patients consulting in other languages.
How CancerFax Helps You Access Dr. Eli Rosenbaum
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Eli Rosenbaum's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Eli Rosenbaum's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Eli Rosenbaum before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Eli Rosenbaum's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Eli Rosenbaum's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Eli Rosenbaum's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Eli Rosenbaum
Prof. Eli Rosenbaum, MD, is a senior oncologist specialising in genitourinary oncology at Rabin Medical Center's Davidoff Cancer Center in Petah Tikva, Israel. He has over 20 years of clinical experience treating prostate cancer, kidney cancer, bladder cancer and other urological malignancies.
Prof. Rosenbaum specialises in genitourinary cancers, including prostate cancer (localized, high-risk, metastatic and castration-resistant), kidney cancer (renal cell carcinoma), bladder cancer (muscle-invasive and advanced urothelial carcinoma), and testicular cancer.
International patients can seek a consultation or second opinion from Prof. Rosenbaum by submitting their medical records through CancerFax. The CancerFax team will review the case, prepare the documents for submission and coordinate the next steps with Rabin Medical Center, subject to hospital availability and case acceptance.
To request a second opinion, submit your medical documents through CancerFax. These should include the latest pathology report, imaging (CT, MRI, PET-CT or bone scan), PSA trend (for prostate cancer), treatment history, blood reports, and any molecular or genomic testing results. The CancerFax team will coordinate the review and consultation process.
Prof. Rosenbaum's prostate cancer treatment approach may include novel hormonal agents such as enzalutamide and abiraterone, chemotherapy, coordination of radiation therapy, and evaluation for radioligand therapy or clinical trials depending on disease stage and prior treatment. Treatment decisions are made following thorough review of the individual patient's pathology, imaging and overall health.
Prof. Rosenbaum practices at the Uro-Oncology Clinic of the Davidoff Cancer Center, Rabin Medical Center, located in Petah Tikva, Israel. Rabin Medical Center is one of Israel's largest tertiary medical centres and the Davidoff Cancer Center is a comprehensive oncology facility.
Connect with Eli Rosenbaum Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.